Skip to main content

Table 3 Methylation Δbeta values (methylation frequencies) between various tumor characteristics.

From: Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

Gene CpG site INRG (M/L) 1p-dela MNAa 11q-dela 17q-gaina >18 m
SCNN1A cg18738906 0.33*** 0.15 0.21** 0.25*** 0.34*** 0.15*
  cg26215727 0.15** 0.04 0.13* 0.17** 0.20*** 0.09
PRKCDBP cg05628549 0.09 -0.06 0.12 0.08 0.09 -0.10
  cg16245261 0.17* 0.00 0.27*** 0.15 0.19* 0.01
  cg18392783 0.12 -0.06 0.18** 0.10 0.12 -0.02
  cg18959478 0.12 -0.06 0.16* 0.10 0.11 -0.04
KRT19 cg11462865 0.14 -0.01 0.19* 0.10 0.12 0.22**
  cg16585619 0.01 -0.05* 0.07*** 0.04* 0.03 0.01
TGFBI cg00386408 0.05 -0.04 0.11 0.10 0.07 0.14*
  cg21034676 0.04 -0.04 0.13 0.06 0.05 0.12
POU2F2 cg21608489 -0.08 -0.05 -0.08 -0.01 -0.04 -0.08
  cg22054191 0.03 -0.03 -0.01 0.04 0.02 0.04
DUSP23 cg10663017 0.06 -0.10 0.27*** 0.21*** 0.16** 0.07
  cg11104347 0.05 -0.13* 0.29*** 0.16** 0.13** 0.08
DHRS3 cg01346152 -0.13 -0.03 -0.20** -0.03 -0.08 -0.10
  cg09229231 0.004* 0.00 0.00 0.00 0.00 0.00
COL1A2 cg18511007 0.07 0.00 0.05 0.07 -0.01 0.18**
  cg25300386 0.02 -0.04 -0.02 0.02 -0.09 0.15*
  1. M, metastatic; L, localized; 1p-del, 1p-deletion; MNA, MYCN amplification; 11q-del, 11q-deletion; m, months; apresence of chromosomal aberration tested against absence; *p ≤ 0.05; **p < 0.01; ***p < 0.001